Venture Capital
Hearing loss for many people is hereditary—a mutation in a single gene impairs hearing from birth. There are no approved drugs for this type of hearing loss, but biotech startup Akouos is developing a gene therapy to help patients recover the ability to hear. Boston-based Akouos says it has secured a $50 million financial commitment […]

In this article